Capital Investment Advisors LLC Has $1.30 Million Holdings in Danaher Co. (NYSE:DHR)

Capital Investment Advisors LLC increased its position in shares of Danaher Co. (NYSE:DHR - Free Report) by 265.5% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 5,640 shares of the conglomerate's stock after purchasing an additional 4,097 shares during the period. Capital Investment Advisors LLC's holdings in Danaher were worth $1,295,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also added to or reduced their stakes in the company. FMR LLC lifted its holdings in shares of Danaher by 15.8% during the third quarter. FMR LLC now owns 23,617,424 shares of the conglomerate's stock worth $6,566,116,000 after buying an additional 3,217,631 shares in the last quarter. Legal & General Group Plc raised its stake in Danaher by 2.4% in the 2nd quarter. Legal & General Group Plc now owns 5,964,031 shares of the conglomerate's stock worth $1,490,112,000 after purchasing an additional 139,989 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in Danaher by 3.0% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 5,097,986 shares of the conglomerate's stock valued at $1,417,342,000 after purchasing an additional 148,251 shares during the period. Fisher Asset Management LLC grew its position in shares of Danaher by 2.6% during the 3rd quarter. Fisher Asset Management LLC now owns 4,552,640 shares of the conglomerate's stock worth $1,265,725,000 after purchasing an additional 116,299 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its holdings in shares of Danaher by 17.6% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,582,982 shares of the conglomerate's stock worth $996,141,000 after purchasing an additional 535,254 shares during the period. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on DHR shares. KeyCorp boosted their price target on Danaher from $290.00 to $310.00 and gave the company an "overweight" rating in a research note on Wednesday, October 23rd. Royal Bank of Canada reduced their target price on Danaher from $333.00 to $311.00 and set an "outperform" rating on the stock in a report on Wednesday, October 23rd. TD Cowen boosted their price target on Danaher from $310.00 to $315.00 and gave the company a "buy" rating in a research note on Wednesday, October 23rd. Bank of America raised shares of Danaher from a "neutral" rating to a "buy" rating and set a $290.00 price objective for the company in a research report on Friday, December 13th. Finally, Guggenheim initiated coverage on shares of Danaher in a research report on Thursday, December 19th. They issued a "buy" rating and a $275.00 target price for the company. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $286.80.

Danaher Price Performance

Shares of DHR opened at $237.58 on Wednesday. The business has a 50-day simple moving average of $235.27 and a two-hundred day simple moving average of $253.56. Danaher Co. has a 12-month low of $222.53 and a 12-month high of $281.70. The stock has a market cap of $171.60 billion, a PE ratio of 45.34, a PEG ratio of 4.32 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the business earned $2.02 EPS. The firm's quarterly revenue was up 3.1% on a year-over-year basis. Analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a $0.27 dividend. The ex-dividend date of this dividend is Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.45%. Danaher's payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.